Phase 1 BCC Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
Basal Cell Carcinoma (BCC)
Nathalie Zeitouni20 enrolled1 locationNCT06623201
Recruiting
Phase 1
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
MelanomaHead and Neck Squamous Cell CarcinomaMetastatic Cancer+16 more
Memorial Sloan Kettering Cancer Center56 enrolled7 locationsNCT05859074
Completed
Phase 1
A phase I study of the Dz13 drug targeting the c-Jun gene in subjects with skin cance (nodular Basal Cell Carcinoma).
Nodular Basal Cell Carcinoma (BCC)
University of New South Wales9 enrolled1 locationACTRN12610000162011